|
|
Immunization ScienceEffectiveness over time of varicella vaccine
The articleEffectiveness Over Time of Varicella Vaccine. Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, and Shapiro ED. JAMA 2004(291):851-855. The questionHow effective is varicella (chickenpox) vaccine over time? Is effectiveness affected by age at the time of vaccination? The studyResearchers identified 339 children 13 months of age or older with chickenpox from twenty pediatric practices in southern Connecticut and compared each of these children with 2 children of the same age who had not had chickenpox. Then they analyzed their medical records to see which children were vaccinated against varicella, at what age they were immunized, and for the severity of their chickenpox illness. The findingsThe effectiveness of the chickenpox vaccine at preventing all chickenpox symptoms during the first year after vaccination was 97%, which decreased to 86% in the second year after vaccination and to 81% in years 7 to 8 after vaccination. The vaccine's effectiveness in year 1 was substantially lower if the vaccine was administered at younger than 15 months (73%) than if it was administered at 15 months or older (99%) but the effectiveness was not much different for subsequent years. Chickenpox was much milder in vaccinated than unvaccinated children regardless of when they were immunized, even after 8 years. “This study indicates that at least through the first 8 years after vaccination, the overall effectiveness of live, attenuated varicella vaccine remains good, although breakthrough varicella is not rare,” the researchers wrote. “Most vaccinated children who develop chickenpox have mild disease, regardless of their age at the time of vaccination or the time since vaccination; at least up to 7 to 8 years after vaccination (the vaccine's effectiveness against moderate to severe disease is excellent throughout the period of the study).” The relevance/bottom lineChickenpox vaccine was licensed in 1995 and therefore had only been in routine use in the U.S. for up to 7 to 8 years at the time of this study. Although the vaccine’s effectiveness to protect against all chickenpox symptoms decreases after the first year, it is still protective after 8 years. Further studies will be needed to assess whether the vaccine remains effective for a longer period. NNii’s CommentThis study is reassuring in that protection against chickenpox appears to be long lasting; children who were immunized but who later developed chickenpox had very mild episodes. The questions that arise from this and other recent studies are what is the ideal immunization strategy for chickenpox; whether there should be a second dose of varicella vaccine for all children, whether varicella vaccination should be given after 15 months of age, and how contagious this so-called breakthrough disease is for unvaccinated children. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Home | About NNii | Contact Us | Contribute | Disclaimer | Site Map | ||
© Copyright 2005. National Network for Immunization Information (NNii). The information contained in the NNii Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances. |